Buy CagriSema in Canada: The Complete Cagrilintide + Semaglutide Buyer's Guide

Buy CagriSema cagrilintide semaglutide blend Canada research peptide Durham Peptides

CagriSema is one of the most in-demand metabolic research peptides in the Canadian market right now, driven by its advanced Phase 3 clinical program and a headline NEJM readout. But because it's a blend of two separate peptides, the buying decision carries a consideration that single-compound purchases don't: you're verifying two peptides, in the correct ratio, not one. This guide covers the full CagriSema purchase decision — what to evaluate, how per-component verification works, blend versus separate vials, pricing, and storage.

For the science behind CagriSema, start with What Is CagriSema?. This article focuses on buying.

The Blend-Specific Consideration: Per-Component Verification

For a single peptide, a COA confirms one identity and one purity number. For a blend, a research-grade COA should confirm both components — that cagrilintide and semaglutide are each present, correctly identified by mass spectrometry, and meet the purity threshold. A COA that reports only an aggregate figure, or tests only one component, leaves the most important questions unanswered: is the ratio right, and are both peptides actually there?

Durham Peptides' CagriSema blend is Janoshik-tested to ≥99% purity per component, with mass-spec identity confirmation for both cagrilintide and semaglutide, on an independently verifiable COA. For how to read those reports, see How to Read a Janoshik COA and How to Verify a Janoshik Certificate of Analysis.

The Standard Six Criteria, Applied to CagriSema

The broader supplier-evaluation framework still applies — see 5 Things to Look for in a Canadian Peptide Supplier:

1. Third-party testing with a verifiable COA (here, for both components)

2. ≥99% HPLC purity per component, with MS identity

3. Synthetic, vegan manufacturing — Durham Peptides' blend is 100% synthetic, no animal derivatives (Vegan Peptides)

4. Canadian domestic shipping — same-day from Ontario (How Durham Peptides Ships)

5. Transparent CAD pricing

6. Research-use-only framing

What Durham Peptides' CagriSema Offers

The CagriSema Blend:

• 10mg total — 5mg cagrilintide + 5mg semaglutide, 1:1 ratio

• ≥99% purity per component, HPLC-verified with MS identity for both

• Janoshik Analytical testing with a verifiable COA key for both components

• 100% synthetic / vegan

• Same-day shipping across Canada before 5:00 PM EST

• C$145.00

Understanding CagriSema Pricing

At C$145, CagriSema is one of Durham Peptides' premium SKUs, and the price reflects two things: it's a dual-componentvial (two peptides, two verification processes), and cagrilintide in particular is a more complex, costlier peptide to manufacture than the common single compounds. When comparing across suppliers, the meaningful comparison is price per

milligram of verified, per-component-tested material — not the sticker price alone.

A lower price from a supplier that tests only one component, or provides no verifiable COA, isn't a saving — it's an unknown ratio and unknown purity feeding directly into sensitive metabolic readouts. For the broader pricing logic, see Retatrutide Price in Canada: What You're Really Paying For, which lays out the same per-mg, quality-adjusted reasoning.

CagriSema Blend vs Buying the Components Separately

A reasonable question is whether to buy the blend or source cagrilintide and semaglutide separately. Durham Peptides stocks semaglutide individually but does not currently stock cagrilintide as a standalone — so for most Canadian researchers, the blend is the practical route to studying the cagrilintide + semaglutide combination.

Option	Contents	Price	Availability
CagriSema Blend	5mg cagrilintide + 5mg semaglutide	C$145.00	In stock
Semaglutide	10mg single	C$64.99	In stock
Cagrilintide (standalone)	—	—	Not currently stocked

For combination research at the studied 1:1 ratio, the blend is the efficient choice — one vial, one reconstitution, consistent per-unit amounts of both peptides, and per-component verification already done.

Storage After Purchase

• Lyophilized: 2–8°C short-term, -20°C long-term, protected from light and moisture

• After reconstitution: refrigerate; both fatty-acid-lipidated peptides are stable co-reconstituted in bacteriostatic water

• Avoid freeze-thaw cycling of reconstituted material

See Peptide Storage Guide and the peptide calculator for reconstitution volumes.

Frequently Asked Questions

Where can I buy CagriSema in Canada? Durham Peptides supplies the CagriSema Blend (cagrilintide 5mg + semaglutide 5mg) for laboratory use only, Janoshik-verified per component and shipped same-day from Ontario.

How much does CagriSema cost in Canada? Durham Peptides' CagriSema blend is C$145.00 for a 10mg vial. Compare suppliers on price per milligram of verified, per-component-tested material.

Can I buy cagrilintide separately? Durham Peptides stocks semaglutide individually but not cagrilintide as a standalone, so the blend is the practical route to the combination. The blend supplies both at a 1:1 ratio.

Is the CagriSema blend tested for both components? Yes — Janoshik tests to ≥99% purity per component with mass-spec identity for both cagrilintide and semaglutide, on a verifiable COA.

Does CagriSema need refrigeration? Yes — 2–8°C short-term, -20°C long-term lyophilized; refrigerate after reconstitution.

Do I need a license to buy CagriSema in Canada? Research-peptide sales to Canadian buyers do not typically require buyer-level licensing, but the blend is sold for laboratory use only and is not for human or veterinary use.

Final Thoughts

Buying CagriSema well comes down to one blend-specific discipline on top of the usual criteria: insist on per-componentverification, so you know both cagrilintide and semaglutide are present, identified, and pure at the right ratio. Durham Peptides' blend is Janoshik-tested to ≥99% purity for both peptides, on a verifiable COA, at C$145.00.

For the science, see What Is CagriSema?; for the comparison to other multi-mechanism compounds, see CagriSema vs Tirzepatide vs Retatrutide; and for the full catalog, see durhampeptides.ca/category/metabolic-research-peptides.

Selected Research References

1. Garvey WT, Blüher M, Kushner RF, et al. Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity (REDEFINE 1). New England Journal of Medicine. 2025. https://pubmed.ncbi.nlm.nih.gov/40548661/

2. Enebo LB, Berthelsen KK, Kankam M, et al. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Concomitant Administration of Multiple Doses of Cagrilintide with Semaglutide 2·4 mg. The Lancet. 2021;397(10286):1736-1748. https://pubmed.ncbi.nlm.nih.gov/33894838/

3. United States Pharmacopeia. USP Chapter <1225>: Validation of Compendial Procedures. Analytical validation standards applicable to research-compound quality testing.

All products sold by Durham Peptides are for research and laboratory use only. They are not intended for human or animal consumption, diagnosis, treatment, cure, or prevention of any disease.